Mydecine Innovations Group Inc

Change company Symbol lookup

Select an option...

MYCOF Mydecine Innovations Group Inc

GTLS Chart Industries Inc

FOUR Shift4 Payments Inc

POWI Power Integrations Inc

KRT Karat Packaging Inc

MOVE Movano Inc

LPTI Longport Inc

NXPI NXP Semiconductors NV

BR Broadridge Financial Solutions Inc

XERS Xeris Pharmaceuticals Inc

Go

Mydecine Innovations Group Inc. is a Canada-based biopharma and life sciences company. The Company is focused on the research, development and acceptance of alternative nature-sourced medicine. Its portfolio of companies includes Mydecine Health Sciences (MHS), Mindleap Health Inc. (Mindleap) and NeuroPharm, Inc (NPI). MHS is focused on developing fungtional mushroom products and psychedelic medicines for the consumer and professional healthcare market. NPI is a veterans-focused healthcare company that is developing pharmaceutical and natural health products for mental wellness in vulnerable populations, including veterans, emergency medical services (EMS) personnel and other high-risk constituencies. NPI is developing psilocybin-assisted psychotherapy to treat chronic post-traumatic stress disorder (PTSD). Mindleap offers a digital health platform that enables people connect with mental health specialists, who can help them to develop habits for a healthy mind.